Oral News and Research

RSS

The contraceptive pill may reduce risk of developing cancer

Taking the contraceptive pill does not increase a woman's chances of developing cancer and may even reduce the risk for most women, according to a study published on bmj.com today.

12 Sep 2007

GlaxoSmithKline responds to Journal of the American Medical Association articles

GlaxoSmithKline believes that conclusions drawn from the most recent meta-analyses published by Drs. Nissen et. al. and Furberg et. al. in the Journal of the American Medical Association do not confirm a difference in the safety profile of Avandia (rosiglitazone) and Actos (pioglitazone).

12 Sep 2007

Link between nicotine and atherosclerosis

It's well known that smoking cigarettes increases risk for a host of serious health problems from cancer to heart disease. Now a new study from Weill Cornell Medical College in New York City looks at how they do their dirty work by contributing to atherosclerosis, or hardening of the arteries. The evidence points to nicotine, the addictive chemical in cigarettes.

11 Sep 2007

Tendons found to contain a small subset of previously unknown adult stem cells

Tendon, the cord-like tissue that connects muscle to bone, contains a small subset of previously unknown adult stem cells, scientists at the National Institute of Dental and Craniofacial Research (NIDCR) part of the National Institutes of Health, and their colleagues have discovered.

11 Sep 2007

Ovation Pharmaceuticals advances development pipeline with new phase III epilepsy study

OVATION Pharmaceuticals, Inc. announced the initiation of a pivotal Phase III clinical trial evaluating clobazam, a unique 1,5 benzodiazapine with significant anticonvulsant properties, as adjunctive treatment for patients with Lennox-Gastaut syndrome (LGS), one of the most severe forms of childhood epilepsy that frequently persists into adulthood.

5 Sep 2007

Avocado extract stops growth of pre-cancerous cells that lead to oral cancer

Nutrients taken from avocados are able to thwart oral cancer cells, killing some and preventing pre-cancerous cells from developing into actual cancers, according to researchers at Ohio State University.

5 Sep 2007

Ardea Biosciences completes phase 1 trials of HIV drug RDEA806

Ardea Biosciences, Inc. has announced that it has successfully completed Phase 1 single-ascending-dose, multiple-ascending-dose, food-effect, and drug-interaction studies of RDEA806, a novel HIV non-nucleoside reverse transcriptase inhibitor (NNRTI), in healthy volunteers.

5 Sep 2007

Revlimid receives approval in Switzerland for treatment of multiple myeloma

Celgene International Sarl has announced that it's oral cancer drug, Revlimid (lenalidomide) has been granted approval by the Swiss Agency for Therapeutic Products (Swissmedic) for use in combination with dexamethasone as a treatment for patients with multiple myeloma who have received at least one prior therapy.

5 Sep 2007

Secondhand smoke affects pets too

The threat of secondhand smoke to the health of non-smokers has been known for years but now researchers say pets can also suffer from the effects of secondhand smoke.

5 Sep 2007

Detailed picture of prevalence of ADHD in U.S.

Most children in the United States who meet the medically accepted definition of Attention Deficit Hyperactivity Disorder (ADHD) have not been diagnosed by a physician, and are not consistently treated with medications, according to the first national ADHD prevalence study in children based on the "gold standard" of diagnostic criteria, according to a new study conducted by researchers at Cincinnati Children's Hospital Medical Center.

4 Sep 2007

Secondhand smoke and pets

It has been in the news for years about how secondhand smoke is a health threat to nonsmokers. The Center for Disease Control and Prevention indicates that secondhand smoke is attributed with killing thousands of adult nonsmokers annually.

3 Sep 2007

Role of self monitoring in patients with type 2 diabetes

A new study published on bmj.com calls for better advice about home blood glucose monitoring for patients with non-insulin dependent (type 2) diabetes.Type 2 diabetes usually develops in people over 40, especially when the person is overweight.

3 Sep 2007

Lowering homocysteine with B-vitamins does not reduce cardiovascular risk

Secondary prevention with homocysteine-lowering B-vitamins does not reduce risk of death or major cardiovascular events, according to the WENBIT study.

3 Sep 2007

Canadian dental hygiene celebrates independence

Dental hygienists have achieved independence after a 14-year campaign to remove the restrictions that tie dental hygiene to dentistry.

3 Sep 2007

The first clinically available oral direct renin inhibitor shows promise in heart failure

Drugs that block a hormonal cascade, known as the renin-angiotensin-aldosterone system (RAAS), help patients with heart failure. Direct renin inhibitors (DRIs) block the RAAS at its first and rate-limiting step.

2 Sep 2007

Pill box organizers increase HIV patients' adherence and improve viral suppression

Inexpensive pill box organizers are an easy, successful, and cost-effective tool to help patients take their medications as prescribed, according to a new study of low-income urban residents living with HIV infection by authors from the Berkeley School of Public Health and the University of California, San Francisco (UCSF).

30 Aug 2007

HPV vaccines may decrease chances of oral cancer

The Centers for Disease Control report that nearly 25 million women are infected with some form of the Human Papilloma Virus (HPV).

30 Aug 2007

HPV vaccines may lower risk of oral cancer

The Centers for Disease Control report that nearly 25 million women are infected with some form of the Human Papilloma Virus (HPV).

29 Aug 2007

FDA grants orphan drug designation to TREANDA

Cephalon, Inc. announced today that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development granted orphan drug designation for the company's investigational therapy, TREANDA (bendamustine HCl), for the treatment of chronic lymphocytic leukemia (CLL).

29 Aug 2007

Stroke outcome improves when patients continue taking cholesterol-lowering drugs

A new study has illustrated the risks involved when statin treatment is discontinued after a stroke and shows an increased risk of death or dependency is present for up to 90 days.

29 Aug 2007